Publikationer Johan Rönnelid

Publikationer i DiVA

Publikationer i PubMed

Publikationslista för åren 2006-2013


Ett urval av våra publikationer:

  1. Hansson M, Mathsson L, Schlederer T, Israelsson L, Matsson P, Nogueira L, Jakobsson PJ, Lundberg K, Malmström V, Serre G, Holmdahl R, Nystrand R, Klareskog L, Rönnelid J. Validation of a multiplex chip-based for the detection of autoantibodies against citrullinated peptides. Athritis Res Ther, 2012; 14:R201.
     
  2. Mullazehi M, Wick MC, Klareskog L, von Vollenhoven R, Rönnelid J. Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis. Arthritis Res Ther. 2012; 14(3):R100.
     
  3. Åhlin E, Mathsson L, Eloranta ML, Jonsdottir T, Gunnarsson I, Rönnblom L, Rönnelid J.Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE. Lupus. 2012; 21(6):586-95.
     
  4. Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiological progression as compared to antibodies against cyclic citrullinated peptide (anti-CCP). Arthritis Rheum 2008; 58(1):36-45).
     
  5. Elshafie A, Åhlin E, Mathsson L, Elghazali G, Rönnelid J. Immune complex-associated production of granulocyte-macrophage colony-stimulating factor is associated with disease activity and with ongoing sodium stibogluconate therapy in Sudanese patients with visceral leishmaniasis. Journal of Immunology 2007; 178(8);5383-9.
     
  6. Mathsson L, Åhlin E, Sjövall C, Skogh T, Rönnelid J. Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-SSA antibodies. Clin Exp Immunol 2007; 147:513-20.
     
  7. Mullazehi M, Mathsson L, Lampa J, Rönnelid J. High anti-collagen type II antibody levels and induction of pro-inflammatory cytokines by anti-collagen antibody containing immune complexes in vitro characterize a distinct RA phenotype associated with acute inflammation at the time of disease onset. Ann Rheum Dis 2007; 66:537-41.
     
  8. Mullazehi M, Mathsson L, Lampa J, Rönnelid J. Surface-bound immune complexes containing antibodies to collagen type II induce production of TNF-a, IL-1b and IL-8 from peripheral blood mononuclear cells. A potential pathophysiological mechanism for anti-collagen immunity in RA. Arthritis Rheum 2006; 54(6):1759-71.
     
  9. Mathsson L, Lampa J, Mullazehi M, Rönnelid J. Immune complexes from RA patients induce Fc(gamma)RII-dependent and rheumatoid factor-correlated TNF-alpha production from peripheral blood mononuclear cells. Arthritis Res Ther 2006; 28(3); R64.
     
  10. Mathsson L, Tejde A, Carlsson K, Höglund M, Nilsson-Ekdahl K, Nilsson B, Rönnelid J. Cryoglobulin-induced cytokine production via FcgRIIa: inverse effects of complement blockade on the production of TNF-a and IL-10. Implications for the growth of malignant B-cell clones. Br J Haematol 2005; 129:830-838.